Geode Capital Management LLC Increases Stock Holdings in Guardian Pharmacy Services, Inc. $GRDN

Geode Capital Management LLC increased its stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 65.9% in the 2nd quarter, Holdings Channel.com reports. The fund owned 336,701 shares of the company’s stock after acquiring an additional 133,715 shares during the quarter. Geode Capital Management LLC’s holdings in Guardian Pharmacy Services were worth $7,177,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. Parkside Financial Bank & Trust purchased a new position in Guardian Pharmacy Services during the second quarter valued at $41,000. KLP Kapitalforvaltning AS acquired a new position in shares of Guardian Pharmacy Services during the 2nd quarter worth about $75,000. Dynamic Technology Lab Private Ltd purchased a new position in Guardian Pharmacy Services in the 1st quarter valued at about $233,000. Envestnet Asset Management Inc. lifted its stake in Guardian Pharmacy Services by 7.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after buying an additional 805 shares in the last quarter. Finally, Los Angeles Capital Management LLC acquired a new stake in Guardian Pharmacy Services in the 2nd quarter worth about $311,000.

Guardian Pharmacy Services Stock Performance

NYSE GRDN opened at $29.71 on Friday. The stock’s fifty day moving average is $27.47 and its two-hundred day moving average is $24.48. The firm has a market capitalization of $1.88 billion, a P/E ratio of 47.15 and a beta of 0.96. Guardian Pharmacy Services, Inc. has a fifty-two week low of $17.78 and a fifty-two week high of $37.43.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Monday, November 10th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.24 by $0.01. The business had revenue of $377.43 million for the quarter, compared to analyst estimates of $381.16 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%. As a group, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on GRDN shares. Truist Financial increased their target price on Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a report on Friday, November 14th. Weiss Ratings reiterated a “hold (c)” rating on shares of Guardian Pharmacy Services in a research report on Monday. Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Finally, Oppenheimer initiated coverage on shares of Guardian Pharmacy Services in a research note on Friday, October 10th. They set an “outperform” rating and a $30.00 target price on the stock. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $30.67.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.